Compare AVIR & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVIR | GORO |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.1M | 497.8M |
| IPO Year | 2020 | 2011 |
| Metric | AVIR | GORO |
|---|---|---|
| Price | $5.21 | $3.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $10.00 | $1.63 |
| AVG Volume (30 Days) | 239.9K | ★ 1.5M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | $25.99 |
| Revenue Next Year | N/A | $5.78 |
| P/E Ratio | ★ N/A | $70.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $0.62 |
| 52 Week High | $6.45 | $4.24 |
| Indicator | AVIR | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 54.07 |
| Support Level | $5.09 | $3.37 |
| Resistance Level | $5.79 | $4.00 |
| Average True Range (ATR) | 0.23 | 0.23 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 23.53 | 19.28 |
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Goldgroup Mining Inc is focused on the acquisition, exploration and development of stage gold-bearing mineral properties in the Americas. The Companies current gold production and exploration and development related activities are conducted in Mexico. It property portfolio include Cerro Prieto project in Sonora and Pinos Project.